Antacids Market - 2024-2031

January 2024 | 34 pages | ID: A7815E1BA891EN
DataM Intelligence

Abstracts

Antacids Marketis is growing with a CAGR of 3.10% during the forecast period 2026-2035.

The Antacids Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Antacids Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By DRUG CLASS

• Proton pump inhibitors*
• H2 antagonists
• Acid neutralizers

By FORMULATION TYPE

• Tablets*
• Liquids
• Powders

By END-USER

• Hospital pharmacies*
• Retail pharmacies
• Others

Regional Analysis for Antacids Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Antacids Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Market Snippet by Drug class

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. A rise in the Incidence of GERD
    4.1.1.2. Increasing awareness about GERD
  4.1.2. Restraints
    4.1.2.1. Alternative treatments for antacids
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Regulatory Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis

6. BY DRUG CLASS

6.1. Introduction
  6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug class Segment
  6.1.2. Market Attractiveness Index, By Drug class Segment
6.2. Proton pump inhibitors*
  6.2.1. Introduction
  6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028
6.3. H2 antagonists
6.4. Acid neutralizers

7. BY FORMULATION TYPE

7.1. Introduction
  7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation type Segment
  7.1.2. Market Attractiveness Index, By Formulation type segment
7.2. Tablets*
  7.2.1. Introduction
  7.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028
7.3. Liquids
7.4. Powders

8. BY END-USER

8.1. Introduction
  8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), ByEnd-UserSegment
  8.1.2. Market Attractiveness Index, ByEnd-UserSegment
8.2. Hospital pharmacies*
  8.2.1. Introduction
  8.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028
8.3. Retail pharmacies
8.4. Others

9. - BY REGION

9.1. Introduction
  9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  9.1.2. Market Attractiveness Index, By Region
9.2. North America
  9.2.1. Introduction
  9.2.2. Key Region-Specific Dynamics
  9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
  9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation type
  9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.2.6.1. The U.S.
    9.2.6.2. Canada
    9.2.6.3. Mexico
9.3. Europe
  9.3.1. Introduction
  9.3.2. Key Region-Specific Dynamics
  9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
  9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation type
  9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.3.6.1. Germany
    9.3.6.2. The U.K.
    9.3.6.3. France
    9.3.6.4. Italy
    9.3.6.5. Spain
    9.3.6.6. Rest of Europe
9.4. South America
  9.4.1. Introduction
  9.4.2. Key Region-Specific Dynamics
  9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
  9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation type
  9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.4.6.1. Brazil
    9.4.6.2. Argentina
    9.4.6.3. Rest of South America
9.5. Asia Pacific
  9.5.1. Introduction
  9.5.2. Key Region-Specific Dynamics
  9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
  9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation type
  9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.5.6.1. China
    9.5.6.2. India
    9.5.6.3. Japan
    9.5.6.4. Australia
    9.5.6.5. Rest of Asia Pacific
9.6. The Middle East and Africa
  9.6.1. Introduction
  9.6.2. Key Region-Specific Dynamics
  9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
  9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation type
  9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

10. COMPETITIVE LANDSCAPE

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. COMPANY PROFILES

11.1. Pfizer *
  11.1.1. Company Overview
  11.1.2. Product Portfolio and Description
  11.1.3. Key Highlights
  11.1.4. Financial Overview
11.2. GlaxoSmithKline
11.3. Abbott India Private Ltd
11.4. Merck
11.5. Sanofi
11.6. AstraZeneca PLC
11.7. Bayer AG
11.8. Takeda pharmaceuticals
11.9. Sun pharmaceuticals

12. DR REDDY’S LABORATORIES

13. PREMIUM INSIGHTS

14. DATAM INTELLIGENCE

14.1. Appendix
14.2. About Us and Services
14.3. Contact Us